A Phase 1 Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Glioma Undergoing Surgery

Trial Profile

A Phase 1 Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Glioma Undergoing Surgery

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Tozuleristide (Primary)
  • Indications Glioma; Solid tumours
  • Focus Adverse reactions
  • Sponsors Blaze Bioscience
  • Most Recent Events

    • 04 Apr 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 09 Nov 2015 As per Blaze Bioscience media release, interim clinical data from this trial will be presented at the 20th Annual Society for Neuro-Oncology (SNO) Scientific Meeting
    • 20 Jul 2015 Planned number of patients changed from 21 to 30 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top